- Home
- HOPE vs CERT Comparison
HOPE vs CERT Comparison
Compare HOPE & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOPE | CERT |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | N/A | 1546 |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HOPE | CERT |
|---|---|---|
| Price | $11.51 | $8.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $13.25 | ★ $13.88 |
| AVG Volume (30 Days) | 1.0M | ★ 2.0M |
| Earning Date | 01-26-2026 | 11-06-2025 |
| Dividend Yield | ★ 4.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | 0.07 |
| Revenue | ★ $431,631,000.00 | $415,551,000.00 |
| Revenue This Year | $19.31 | $10.82 |
| Revenue Next Year | $12.90 | $6.77 |
| P/E Ratio | ★ $29.84 | $126.84 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $8.83 | $8.03 |
| 52 Week High | $13.50 | $15.69 |
Technical Indicators
Market Signals| Indicator | HOPE | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 69.95 | 40.96 |
| Support Level | $11.40 | $8.95 |
| Resistance Level | $11.66 | $9.42 |
| Average True Range (ATR) | 0.26 | 0.39 |
| MACD | 0.10 | 0.07 |
| Stochastic Oscillator | 88.63 | 25.99 |
Price Performance
Historical ComparisonAbout HOPE Hope Bancorp Inc.
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services and other banking services.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.